Analytical Data
-
Gene name
LPS
- Application
-
Alternative Names
LPS；BMP14；CDMP1；Growth/differentiation factor 5
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P43026
-
Expression Region
382-501aa
-
AA Sequence
APLATRQGKR PSKNLKARCS RKALHVNFKD MGWDDWIIAP LEYEAFHCEG LCEFPLRSHL EPTNHAVIQT LMNSMDPEST PPTCCVPTRL SPISILFIDS ANNVVYKQYE DMVVESCGCR
-
Molecular Weight
13.6 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LPS (lipopolysaccharide) recombinant proteins have garnered significant attention in the field of immunology and biotechnology due to their crucial role in the activation of the immune system. LPS are large molecules found in the outer membrane of gram-negative bacteria, and they play a pivotal role in triggering innate immune responses. The study of LPS has been instrumental in understanding how the immune system recognizes pathogens, leading to the activation of various immune cells and the production of pro-inflammatory cytokines. However, natural LPS is often toxic and difficult to handle, presenting challenges for research and therapeutic applications. Recombinant proteins derived from LPS provide a promising alternative, allowing for safer and more controlled studies. By engineering these proteins through recombinant DNA technology, researchers can produce LPS components in a laboratory setting, enabling in-depth investigations into their immunological effects and potential applications in vaccine development and immune modulation. Furthermore, the use of LPS recombinant proteins can aid in the development of diagnostic tools and the study of bacterial pathogenesis, ultimately contributing to better understanding and treatment of infectious diseases. This area of research continues to evolve, with advances in biotechnology paving the way for novel applications in medicine and immunotherapy.
